GC-MS and multivariate analysis reveal partial serum metabolome restoration by bevacizumab in a colon cancer rat model: An untargeted metabolomics investigation.

MLA

Abduljabbar, Maram H., et al. “GC-MS and Multivariate Analysis Reveal Partial Serum Metabolome Restoration by Bevacizumab in a Colon Cancer Rat Model: An Untargeted Metabolomics Investigation.” Journal of Pharmaceutical & Biomedical Analysis, vol. 253, Jan. 2025, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jpba.2024.116562.

APA

Abduljabbar, M. H., Althobaiti, Y. S., Alnemari, R. M., Almutairi, F. M., Aldhafeeri, M. M., Serag, A., & Almalki, A. H. (2025). GC-MS and multivariate analysis reveal partial serum metabolome restoration by bevacizumab in a colon cancer rat model: An untargeted metabolomics investigation. Journal of Pharmaceutical & Biomedical Analysis, 253, N.PAG. https://doi.org/10.1016/j.jpba.2024.116562

Chicago

Abduljabbar, Maram H., Yusuf S. Althobaiti, Reem M. Alnemari, Farooq M. Almutairi, Muneef M. Aldhafeeri, Ahmed Serag, and Atiah H. Almalki. 2025. “GC-MS and Multivariate Analysis Reveal Partial Serum Metabolome Restoration by Bevacizumab in a Colon Cancer Rat Model: An Untargeted Metabolomics Investigation.” Journal of Pharmaceutical & Biomedical Analysis 253 (January): N.PAG. doi:10.1016/j.jpba.2024.116562.